Source: Clinical infectious diseases. Unidade: FM
Subjects: COVID-19, PACIENTES INTERNADOS, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WHITTAKER, Charles et al. Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: a Modelling Analysis. Clinical infectious diseases, v. 75, n. 1, p. E224-E233, 2022Tradução . . Disponível em: https://doi.org/10.1093/cid/ciab837. Acesso em: 20 ago. 2024.APA
Whittaker, C., Watson, O. J., Alvarez-Moreno, C., Angkasekwinai, N., Boonyasiri, A., Triana, L. C., et al. (2022). Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: a Modelling Analysis. Clinical infectious diseases, 75( 1), E224-E233. doi:10.1093/cid/ciab837NLM
Whittaker C, Watson OJ, Alvarez-Moreno C, Angkasekwinai N, Boonyasiri A, Triana LC, Chanda D, Costa SF, Levin ASS, Sabino EC. Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: a Modelling Analysis [Internet]. Clinical infectious diseases. 2022 ; 75( 1): E224-E233.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1093/cid/ciab837Vancouver
Whittaker C, Watson OJ, Alvarez-Moreno C, Angkasekwinai N, Boonyasiri A, Triana LC, Chanda D, Costa SF, Levin ASS, Sabino EC. Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: a Modelling Analysis [Internet]. Clinical infectious diseases. 2022 ; 75( 1): E224-E233.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1093/cid/ciab837